Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CSPG4 pseudogene 4 Y-linked (CSPG4P4Y) is classified as a pseudogene on the human Y chromosome[2]. It derives its name from homology to the CSPG4 gene, which encodes chondroitin sulfate proteoglycan 4, but CSPG4P4Y itself does not encode a functional protein. There is no evidence that this Y-linked pseudogene produces a functional product, participates in physiological processes, or is involved in disease or therapeutic targeting. The "pseudogene" designation by the HUGO Gene Nomenclature Committee (HGNC) confirms its non-functional status. If you intended to inquire about the active gene (CSPG4) or its encoded protein ("Chondroitin sulfate proteoglycan 4"), see the information for CSPG4, which is a membrane-bound proteoglycan implicated in cell adhesion, melanoma, and oligodendrocyte biology[1][4][7]. For CSPG4P4Y, however, no therapeutic or biological activity is reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CSPG4 pseudogene 4 Y-linked (CSPG4P4Y).